Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug

US6124270A · kind A · utility

Assignee

• Pasteur Mérieux Sérums et Vaccins S.A. · FR

Inventor

• Jean Haensler · Pollionnay, FR

Key dates

• Filing date: Mar 3, 1997
• Grant date: Sep 26, 2000
• Expiry date: Mar 3, 2017

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S424/812
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A cationic amphipathic compound of formula (I), ##STR1## wherein A is a single bond, an NH--R' grouping or (a), wherein --R'-- is a straight or branched, optionally substituted, saturated or unsaturated C.sub.1-22 aliphatic chain optionally interrupted by one or more O, S or N heteroatoms and one or more saturated, unsaturated or aromatic carbocyclic or heterocyclic radicals; each of R.sub.1, R.sub.2 and R.sub.3, which are the same or different, is a higher acyl or alkyl grouping; each of R.sub.7, R.sub.8 and R.sub.9, which are the same or different, is a (CH.sub.2).sub.n alkylene radical where 1.ltoreq.N.ltoreq.6; each of R.sub.4, R.sub.5 and R.sub.6, which are the same or different, is a hydrogen atom or an optionally substituted C.sub.1-22 alkyl, alkenyl, alkynyl or acyl radical optionally interrupted by one or more heteroatoms selected from), S and N, or one or more saturated, unsaturated or aromatic carbocyclic or heterocyclic radicals, or else at least two of the groupings R.sub.4, R.sub.5 and R.sub.6, taken together with the nitrogen atom to which they are attached, form a quinuclidino, piperidino, pyrrolidino or morpholino grouping, and X is a non-toxic anion. For use as a …